AU8277582A - Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them - Google Patents
Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing themInfo
- Publication number
- AU8277582A AU8277582A AU82775/82A AU8277582A AU8277582A AU 8277582 A AU8277582 A AU 8277582A AU 82775/82 A AU82775/82 A AU 82775/82A AU 8277582 A AU8277582 A AU 8277582A AU 8277582 A AU8277582 A AU 8277582A
- Authority
- AU
- Australia
- Prior art keywords
- hybride
- dna
- virus
- plasmic
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3112338.4 | 1981-03-28 | ||
DE3112338A DE3112338C2 (en) | 1981-03-28 | 1981-03-28 | Use of hybridization probes for the detection of HAV |
PCT/EP1982/000066 WO1982003408A1 (en) | 1981-03-28 | 1982-03-26 | Method for the preparation of a dna-hybride,containing the complementary genome of the hepatitis a virus,the dna-hybride itself,the plasmic vector contain it,the specific proteins of the virus coded by the dna-hybride and vaccins containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8277582A true AU8277582A (en) | 1982-10-19 |
Family
ID=25792219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU82775/82A Abandoned AU8277582A (en) | 1981-03-28 | 1982-03-26 | Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU8277582A (en) |
-
1982
- 1982-03-26 AU AU82775/82A patent/AU8277582A/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8223187A (en) | T cell epitopes of the hepatitis b virus nucleocapsid protein | |
AU7966987A (en) | Empty viral capsid vaccines | |
DE3176404D1 (en) | Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine | |
ZA826154B (en) | Infectious bronchitis vaccines for poultry, process for the preparation of such vaccines, process for preventing infectious broachitis and infectious bronchitis virus strain | |
GB2212511B (en) | Hepatitis c virus | |
GB2199328A (en) | Translation of mrna | |
EP0466815A4 (en) | Infectious targetted replication-defective virion | |
NZ211880A (en) | Immunogenic, leukemia-associated viral proteins and vaccines | |
AU506385B2 (en) | Hepatitis b virus; isolation for vaccines | |
PT75643B (en) | Method for preparing dna,recombinant dna hosts containing them and polipeptides | |
AU8746582A (en) | Hepatitis b virus e type antigen | |
DE3266294D1 (en) | Method for the preparation of antigens of the viral hepatitis nanb, and application to the preparation of a reaction agent allowing the diagnosis and prognosis of infections caused by the viruses of viral hepatitis | |
ZA848857B (en) | Psoralen inactivated double-stranded rna viral vaccines | |
JPS57144227A (en) | Manufacture of b type hepatitis vaccine | |
BG50281A3 (en) | Method for the preparation of a recombination dna expression vector | |
AU1076983A (en) | Infectious bronchitis vaccines | |
GB2111829B (en) | A process for the preparation of lyophilized vaccine against duck hepatitis | |
EP0245456A4 (en) | Aids virus gene expression. | |
AU3597089A (en) | Method for producing nonhyperglycosylated hepatitis b virus proteins | |
EP0518313A3 (en) | Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same | |
IL76417A (en) | Vaccine for hepatitis a virus based on strain hm-175 | |
LTIP1795A (en) | Process for preparing protein derived from the envelope gene of human immunodeficiency virus type i and a vaccine containing said protein | |
EP0549964A3 (en) | Process for preparing a virus inactivated prothrombin complex concentrate | |
AU8277582A (en) | Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them | |
AU561920B2 (en) | Hepatitis b and hep non a, non b safe biological products |